The News

Press releases

New research from Genomics and Stanford Medicine indicates polygenic risk score screening could prevent almost a third of premature, preventable deaths


26 Nov 2024

Our research shows very high risk individuals reached the risk levels associated with usual starting screening ages 12.4 years earlier, on average. In other words, if a screening programme were devised on the basis of the average risk facing a 50-year-old, this high risk group would have the same predicted risk at the age of 37.6. Recommendations for earlier screening for genetically very high risk groups ranged from four years in advance for abdominal aortic aneurysm, to 22 years for hypertension.

Read article

ASHG 2024: New study from Genomics indicates individuals who have a genetic predisposition for high BMI may require tailored approaches to tackle obesity


12 Nov 2024

Our research shows that those at high genetic risk of obesity will need personalised support to help them stay at, or return to, a healthy weight.

Read article

Genomics releases new research showing significant link between genetic risk and obesity


16 Oct 2024

Genomics releases new research showing significant link between genetic risk and obesity

Read article

Genomics Announces David Thornton as President


30 Sep 2024

Genomics announces the appointment of David Thornton to the position of President, succeeding Professor Gil McVean, who will join the board as a non-executive Director.

Read article

Genomics plc identifies increased levels of undetected risk of heart disease in UK population


18 Sep 2024

Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).

Read article

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex


17 Jul 2024

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups

Read article

Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design


30 Apr 2024

The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency

Read article

Genomics and MassMutual's program enables understanding health risks through genetic testing


9 Apr 2024

The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer

Read article

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Read article

Genomics plc bolsters executive leadership team with two new hires


25 Nov 2022

Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.

Read article